Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Ginkgo and Reduced Dizziness Severity

Safety in these studies

Overall tolerabilityReported
The intervention was generally well tolerated, with significantly lower risks of angina pectoris (OR 0.51, 95% CI 0.31 to 0.85) and tinnitus (OR 0.37, 95% CI 0.22 to 0.63) and no significant increase in other adverse events.
from: Ginkgo biloba extract for dizziness-related symptoms in central neurological disorders: a

1 of 1 paper

Ginkgo biloba extract for dizziness-related symptoms in central neurological disorders: a systematic review and meta-analysis.
- 2026-06-18
- Systematic Review
- Frontiers in neurology 17
- - Young-Hyo Jeon
  - Jeong Ah Kim
  - Dong Yoon Kang
  - Seunghyun Lee
  - Nam-Kyong Choi
  - Ji-Yun Park
- PubMed: 42394931
- DOI: 10.3389/fneur.2026.1860538
3 Insights on
- Reduced Dizziness Severity
- High evidence
- Clinical
Ginkgo biloba significantly reduced dizziness/vertigo severity on the 11-point box scale (MD -0.76, 95% CI -1.35 to -0.18; p=0.01) and VAS (SMD -0.38, 95% CI -0.58 to -0.19; p=0.0001).
Effect
Beneficial
Effect size
Moderate
Significant
Yes